al successes, makes it a potentially valuable adjunct for motivated patients seeking alternative approaches. However, users should approach it with a critical mind, recognizing the limitations of anecdotal evidence and the need for personalized medical advice. It is not a substi
ing the paradigm of cancer treatment, offering hope to patients who previously faced limited options. As laser technologies continue to evolve and research uncovers new applications, LIITI’s role is poised to expand further, setting standards and fostering global collaboration in the fi
ity Pneumonitis (HP) Clinical Background: A 40-year-old bird breeder with episodic cough, chills, and dyspnea after exposure. HRCT Findings: Diffuse ground-glass opacities with centrilobular nodules Mosaic attenuation indicating air trapping Areas of air trapping visible on expiratory scans No
k explores: Novel Antifibrotic Agents: Investigational drugs targeting molecular pathways involved in fibrosis Biologic Therapies: Monoclonal antibodies and cytokine inhibitors Personalized Medicine: Genetic profiling for tailored therapy Biomarkers: For early diagnosis, prognosis, and
